Optimized adalimumab therapy maintains remission in some patients with Behçet-related uveitis

• Posted on: Dec 2 2019
• By: Saratoga Opthalmology
• Leave a response

Researchers assessed the efficacy of optimized adalimumab therapy in a large series of patients with uveitis due to Behçet disease.
Source: AAO

Posted in: Uncategorized